Status:
COMPLETED
Ev-AIFIB Preliminary Evaluation of the AIFib Software
Lead Sponsor:
Hospital St. Joseph, Marseille, France
Conditions:
Software Performance Evaluation a Posteriori
Eligibility:
All Genders
18+ years
Brief Summary
To evaluate the intraoperative effectiveness of the AIFIB software in real time in the detection of atrial fibrillation drivers during an ablation procedure.
Eligibility Criteria
Inclusion
- Patients 18 years of age or older
- Etiology in the following list:
- Atrial fibrillation for which a conventional anatomical approach alone (pulmonary vein isolation) is not performed: persistent AF, long standing persistent AF paroxysmal AF (redo), paroxysmal AF
- Atrial tachycardia de novo or secondary to AF ablation.
Exclusion
- Contraindication to AF ablation
- Major bleeding disorder
Key Trial Info
Start Date :
July 17 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2020
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03434964
Start Date
July 17 2018
End Date
July 31 2020
Last Update
June 23 2021
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hopitaux Institut Catholique de Lille
Lille, France
2
Clinique de l'Infirmerie Protestante
Lyon, France
3
Saint Joseph Hospital
Marseille, France, 13008
4
Clinique Ambroise Paré, Neuilly
Neuilly-sur-Seine, France